Use of ginsenoside rg1, its metabolites ginsenoside rh1 and/or ppt

Use of an active ingredient selected from ginsenoside Rg1, its metabolites ginsenoside Rh1 and Ppt for preparing a medicament and a health care product for increasing content of testosterone in serum of male mammals, and increasing content of cGMP in corpus cavernosum.

Use of an active ingredient selected from ginsenoside Rg1, its metabolites ginsenoside Rh1 and Ppt for preparing a medicament and a health care product for providing the effect of spermatogenesis.

Use of an active ingredient selected from ginsenoside Rg1, its metabolites ginsenoside Rh1 and Ppt for preparing a medicament and a health care product for treating impotence, man sterility, and for improving reduced number and quality of sperms of man.

A pharmaceutical composition for improving sexual function of male mammals, and/or for providing the effect of spermatogenesis, which comprises a therapeutically effective amount of at least one active ingredient selected from ginsenoside Rg1, its metabolites ginsenoside Rh1 and Ppt, and optionally a pharmaceutically acceptable excipient.

A method for improving sexual function and/or spermatogenesis of male mammals, comprising administering to a subject a therapeutically effective amount of at least one active ingredient selected from ginsenoside Rg1, its metabolites ginsenoside Rh1 and Ppt.